396 related articles for article (PubMed ID: 29157179)
21. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.
Enders G; Bäder U; Lindemann L; Schalasta G; Daiminger A
Prenat Diagn; 2001 May; 21(5):362-77. PubMed ID: 11360277
[TBL] [Abstract][Full Text] [Related]
22. ToRCH "co-infections" are associated with increased risk of abortion in pregnant women.
Rasti S; Ghasemi FS; Abdoli A; Piroozmand A; Mousavi SG; Fakhrie-Kashan Z
Congenit Anom (Kyoto); 2016 Mar; 56(2):73-8. PubMed ID: 26499091
[TBL] [Abstract][Full Text] [Related]
23. [Prevalence of positive sorology for HIV, hepatitis B, toxoplasmosis and rubella in pregnant women from the northwestern region of the state of Paraná].
Ferezin RI; Bertolini DA; Demarchi IG
Rev Bras Ginecol Obstet; 2013 Feb; 35(2):66-70. PubMed ID: 23412005
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of TORCH infections in women of childbearing age in Croatia.
Vilibic-Cavlek T; Ljubin-Sternak S; Ban M; Kolaric B; Sviben M; Mlinaric-Galinovic G
J Matern Fetal Neonatal Med; 2011 Feb; 24(2):280-3. PubMed ID: 20476874
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of preconception TORCH infections and its influential factors: evidence from over 2 million women with fertility desire in southern China.
Han L; Li R; Xiong W; Hu Y; Wu J; Liu X; Nie H; Qin W; Ling L; Li M
BMC Womens Health; 2023 Aug; 23(1):425. PubMed ID: 37563634
[TBL] [Abstract][Full Text] [Related]
26. Impact of Syrian refugees on congenital TORCH infections screening in Turkey.
Çoşkun B; Gülümser Ç; Çoşkun B; Artuk C; Karaşahin KE
J Obstet Gynaecol Res; 2020 Jul; 46(7):1017-1024. PubMed ID: 32343041
[TBL] [Abstract][Full Text] [Related]
27. The Screening of
Nabizadeh E; Ghotaslou A; Salahi B; Ghotaslou R
Infect Dis Obstet Gynecol; 2022; 2022():4490728. PubMed ID: 35046632
[TBL] [Abstract][Full Text] [Related]
28. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.
Branch DW; Silver R; Pierangeli S; van Leeuwen I; Harris EN
Obstet Gynecol; 1997 Apr; 89(4):549-55. PubMed ID: 9083311
[TBL] [Abstract][Full Text] [Related]
29. Standardization of an in-house multiplex real-time polymerase chain reaction for the simultaneous detection of
Rajendiran P; Saravanan N; Ramamurthy M; Sankar S; Aruliah R; Nandagopal B; Sridharan G
Indian J Public Health; 2021; 65(4):369-374. PubMed ID: 34975080
[TBL] [Abstract][Full Text] [Related]
30. Seroepidemiology of TORCH antibodies in the reproductive-aged women in China.
Qi Y; Zhu S; Li C; Wu H; Yue H; Zhang Y; Zhu B; Ma J; Feng Z; Kong H; Cai X; Ruan Q
Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():114-118. PubMed ID: 32957008
[TBL] [Abstract][Full Text] [Related]
31. [Seroprevalence rates of Toxoplasma gondii, rubella, cytomegalovirus, syphilis, and hepatitis B, seroprevalences rate in the pregnant population in İstanbul].
Doğan K; Güraslan H; Özel G; Aydan Z; Yaşar L
Turkiye Parazitol Derg; 2014 Dec; 38(4):228-33. PubMed ID: 25732880
[TBL] [Abstract][Full Text] [Related]
32. Serological markers as indicators for congenital cytomegalovirus infection.
Abo-Elwafa HA; Eldin SS; Sharaf AE; Abdelmonem AM
Egypt J Immunol; 2010; 17(2):1-10. PubMed ID: 23082482
[TBL] [Abstract][Full Text] [Related]
33. Anti-cytomegalovirus immunoglobulin M titer for congenital infection in first-trimester pregnancy with primary infection: a multicenter prospective cohort study.
Toriyabe K; Morikawa F; Minematsu T; Ikejiri M; Suga S; Ikeda T
J Perinatol; 2017 Dec; 37(12):1272-1277. PubMed ID: 29022925
[TBL] [Abstract][Full Text] [Related]
34. Seroconversion and seroprevalence of TORCH infections in a pregnant women cohort study, Mombasa, Kenya, 2017-2019.
Hunsperger E; Osoro E; Munyua P; Njenga MK; Mirieri H; Kikwai G; Odhiambo D; Dayan M; Omballa V; Agogo GO; Mugo C; Widdowson MA; Inwani I
Epidemiol Infect; 2024 Feb; 152():e68. PubMed ID: 38305089
[TBL] [Abstract][Full Text] [Related]
35. The association of ToRCH infection and congenital malformations: A prospective study in China.
Wang Y; Li S; Ma N; Zhang Q; Wang H; Cui J; Wang S
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():336-340. PubMed ID: 31382146
[TBL] [Abstract][Full Text] [Related]
36. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies.
Gozzoli GI; Piovani E; Negri B; Mascherpa M; Orabona R; Zanardini C; Zatti S; Piantoni S; Lazzaroni MG; Tomasi C; Prefumo F; Sartori E; Franceschini F; Tincani A; Andreoli L
Front Immunol; 2022; 13():953043. PubMed ID: 36189273
[TBL] [Abstract][Full Text] [Related]
37. The Association Between Previous TORCH Infections and Pregnancy and Neonatal Outcomes in IVF/ICSI-ET: A Retrospective Cohort Study.
Liu Y; Wu Y; Wang F; Wang S; Zhao W; Chen L; Tu S; Qian Y; Liao Y; Huang Y; Zhang R; Xu G; Zhang D
Front Endocrinol (Lausanne); 2020; 11():466. PubMed ID: 32849269
[No Abstract] [Full Text] [Related]
38. Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey.
Tamer GS; Dundar D; Caliskan E
Clin Invest Med; 2009 Feb; 32(1):E43-7. PubMed ID: 19178878
[TBL] [Abstract][Full Text] [Related]
39. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.
Simchen MJ; Dulitzki M; Rofe G; Shani H; Langevitz P; Schiff E; Pauzner R
Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1428-33. PubMed ID: 21729009
[TBL] [Abstract][Full Text] [Related]
40. Line Immunoassay: A Rapid Test for Screening TORCH Complex in Antenatal Patients with Bad Obstetric History.
Kumar H; Singh VA; Isha M; Mehta S; Garg R; Shinu P
Mymensingh Med J; 2018 Jul; 27(3):641-644. PubMed ID: 30141457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
